P

Inventor

GILLIGAN PAUL JOSEPH

US12 patents
⚠️ This page may combine multiple inventors who share the name “GILLIGAN PAUL JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DU PONT PHARM CO

7 patents
US6107301AAug 22, 2000

1N-alkyl-N-arylpyrimidinamines and derivatives thereof

DU PONT PHARM CO192 citations97
US6342503B1Jan 29, 2002

1N-alkyl-n-arylpyrimidinamines and derivatives thereof

DU PONT PHARM CO144 citations95
US6124289ASep 26, 2000

Azolo triazines and pyrimidines

DU PONT PHARM CO57 citations95
US6271380B1Aug 7, 2001

1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands

DU PONT PHARM CO18 citations92
US6258809B1Jul 10, 2001

6-aryloxy and arylthiopurines

DU PONT PHARM CO21 citations92
US6124300ASep 26, 2000

Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives

DU PONT PHARM CO32 citations92
US6107300AAug 22, 2000

Arylamino fused pyrimidines

DU PONT PHARM CO35 citations92

BRISTOL MYERS SQUIBB PHARMA CO

3 patents
US6448261B1Sep 10, 2002

Arylamino fused pyridines

BRISTOL MYERS SQUIBB PHARMA CO55 citations95
US6579876B2Jun 17, 2003

Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists

BRISTOL MYERS SQUIBB PHARMA CO12 citations72
US6365589B1Apr 2, 2002

Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists

BRISTOL MYERS SQUIBB PHARMA CO2 citations61

BRISTOL MYERS SQUIBB CO

2 patents
US6518271B1Feb 11, 2003

1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands

BRISTOL MYERS SQUIBB CO11 citations73
US6521636B1Feb 18, 2003

Imidazo-pyridines as corticotropin releasing factor antagonists

BRISTOL MYERS SQUIBB CO6 citations72